Liposome |
High efficiency, low toxicity, long-term efficacy, ability to deliver both hydrophilic and lipophilic compounds [262] |
Rapid systemic elimination, rapid metabolic degradation of phospholipids. Stability problems associated with long-term storage. Inability to provide sustained drug release. They are only moderately efficient for the encapsulation of lipophilic compounds [[263], [264], [265], [266], [267], [268]] |
Polymeric nanoparticles |
the ability to modify drug release; increase the stability of volatile drug; incorporate into other activities related to drug delivery [269] |
high cost; the preparation process is complex and the reproducibility is low |
Metal nanoparticles |
MRI and magnetic targeting performance; free radical scavenging |
Potential toxicity associated with complex ingredients [270] |
Carbon nanotubes |
High penetration power and surface area; more than one molecule can be conjugated to their surface |
Low biodegradability and dispersivity, possible induced oxidative stress and Lung disease [170,171] |
Graphene |
Polyaromatic structure and higher surface area |
The lack of standardization; Difficult to biodegrade; Damage to the lungs [215,271] |
Black phosphorus |
Biodegradable; selectively capture Cu2+64
|
High cost; difficult to control shape and size |
Hydrogels |
Similar to the flexibility of natural tissue; PH or temperature sensitive; Biocompatible and biodegradable [272] |
Thermosensitive hydrogel may cause excessive or insufficient drug release due to temperature stimulation [273]. |
Dendrimers |
Easy surface modification; ability to interact with charged functional groups [274]. |
The specific toxicology, biocompatibility and in vivo distribution of various dendrimers need further in-depth study [274]. |